Large Disparities in Adoption of Alzheimer's Infusion Therapy Raise Concerns About Access
May 16, 2025
May 16, 2025
LOS ANGELES, California, May 16 -- The UCLA Health issued the following news release:
* * *
Large disparities in adoption of Alzheimer's infusion therapy raise concerns about access
Use of costly breakthrough therapy higher among white, urban affluent males
Adoption of lecanemab, a novel infusion treatment for Alzheimer's disease (AD), has been disproportionately higher among patients who are male, white, from urban areas, and have hi . . .
* * *
Large disparities in adoption of Alzheimer's infusion therapy raise concerns about access
Use of costly breakthrough therapy higher among white, urban affluent males
Adoption of lecanemab, a novel infusion treatment for Alzheimer's disease (AD), has been disproportionately higher among patients who are male, white, from urban areas, and have hi . . .